In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

Pepsi's financial wellness partnership, the growing popularity of GLP-1 weight loss drugs and more top the list of core ...

This is what you need to keep in the back of your mind as you compare Kraft Heinz (NASDAQ: KHC) to Coca-Cola (NYSE: KO). Both ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...